AwardedSWEGoodsFramework agreementSEK 450,000,000
Läkemedel på rekvisition 2026 SLL450 del 2
- Published
- Published 8 December 2025
- Deadline
- Closed 13 January 2026
Overview
Rekvisitionsläkemedel inom olika ATC-koder.
Key details
- Country
- SWE
- Status
- Awarded
- Category
- Goods
- Estimated value
- SEK 450,000,000
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 8 December 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Award date
- 6 February 2026
- Contract period
- 1 May 2026 → 28 February 2031
- Accord Heatlhcare AB
- Amgen AB
- Bayer AB
- Celltrion Sweden AB
- Fresenius Kabi AB
- FrostPharma AB
- Gedeon Richter Nordics AB
- Macure Pharma ApS
- Medac Gesellschaft für klinische Spezialpräparate mbH
- Medical Valley Invest AB
- Orifarm AB
- Orion Pharma AB
- Otsuka Pharma Scandinavia AB
- Roche AB
- Samsung Bioepis NL B.V.
- Sandoz A/S
- Zentiva Denmark ApS
- Öresund Pharma ApS
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
2 July 2026
Contract Award Notice
19 May 2026
Contract Notice
8 December 2025
Contracting authority
Region Stockholm - Fastighets- och servicenämnden/Inköpscentralen
Procuring entityStockholm, SWE
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.